NCT02910323 The Will Erwin Headache Research Center - Cluster Headache Study
| NCT ID | NCT02910323 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The University of Texas Health Science Center, Houston |
| Condition | Cluster Headache |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,500 participants |
| Start Date | 2016-07-12 |
| Primary Completion | 2035-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,500 participants in total. It began in 2016-07-12 with a primary completion date of 2035-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Will Erwin Headache Research Center Study of Cluster Headache and Trigeminal Neuralgia is a prospective, multicenter, observational research network for subjects with Cluster Headache and/or Trigeminal Neuralgia.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of a trigeminal autonomic cephalalgia according to the International Headache Classification including episodic cluster headache, chronic cluster headache, episodic paroxysmal hemicrania, chronic paroxysmal hemicrania, episodic short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT), chronic SUNCT, episodic short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms (SUNA), chronic SUNA, and hemicrania continua. OR Diagnosis of a trigeminal neuralgia according to the International Headache Classification, including classical trigeminal neuralgia and symptomatic trigeminal neuralgia. * Able to provide HIPAA authorization to share prior medical records/imaging. Exclusion Criteria: * Life expectancy less than 1 year, co-existing disease or other characteristic that precludes appropriate diagnosis of a trigeminal autonomic cephalalgia or trigeminal neuralgia. * Active drug or alcohol use or dependence that, in the opinion of the site investigator, would interfere with adherence to study requirements * Inability or unwillingness of subject or legal guardian/representative to give informed consent. Inclusion Criteria for Healthy Volunteers: * Inclusion criteria is willingness to consent and be of age 18 and older
Contact & Investigator
Mark Burish, MD, PhD
PRINCIPAL INVESTIGATOR
The University of Texas Health Science Center, Houston
Frequently Asked Questions
Who can join the NCT02910323 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cluster Headache. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02910323 currently recruiting?
Yes, NCT02910323 is actively recruiting participants. Contact the research team at nctt.wec@uth.tmc.edu for enrollment information.
Where is the NCT02910323 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT02910323 clinical trial?
NCT02910323 is sponsored by The University of Texas Health Science Center, Houston. The principal investigator is Mark Burish, MD, PhD at The University of Texas Health Science Center, Houston. The trial plans to enroll 1,500 participants.